Maintaining Investments in New Innovation Act

House Bill

H.R. 1672

119th Congress

Maintaining Investments in New Innovation Act

In Committee

Introduced:Oct 3, 2025

Primary Sponsor

Danny K. Davis

Representative

Democratic

IL-7

Cosponsors

4

Quick Stats

Policy Area

Health

Summary

The Maintaining Investments in New Innovation Act establishes a demonstration project to improve outpatient care for individuals with sickle cell disease, particularly young adults and pregnant women. The bill provides funding for state Medicaid programs to offer specialized services and support, including multidisciplinary care teams, appropriate treatments, mental health services, and specialist services.

Latest Action

Referred to the Subcommittee on Health.

AI Summary

Plain-English explanation of this bill

The Maintaining Investments in New Innovation Act establishes a demonstration project to improve outpatient care for individuals with sickle cell disease, particularly young adults and pregnant women. The bill provides funding for state Medicaid programs to offer specialized services and support, including multidisciplinary care teams, appropriate treatments, mental health services, and specialist services.

Last updated: 12/29/2025

Official Summary

Congressional Research Service summary

Sickle Cell Disease Comprehensive Care Act This bill establishes and provides funds for a demonstration project for state Medicaid programs to improve outpatient care for individuals with sickle cell disease, with a focus on young adults and pregnant women. The Centers for Medicare & Medicaid Services must award planning grants to at least 10 states and must select between 5 and 10 states to participate in the project. Participating states must provide specified services and support for individuals with sickle cell disease, including multidisciplinary care teams, appropriate treatments, mental health services, and specialist services. The bill provides a 100% Federal Medical Assistance Percentage (i.e., federal matching rate) for services provided through the project.

Key Points

Main provisions of the bill

Establishes a demonstration project to improve outpatient care for individuals with sickle cell disease
Focuses on supporting young adults and pregnant women with sickle cell disease
Provides 100% federal funding for participating state Medicaid programs to offer specialized services and support
Requires participating states to provide multidisciplinary care teams, appropriate treatments, mental health services, and specialist services

How This Impacts Americans

Potential effects on citizens and communities

This bill would directly benefit individuals with sickle cell disease, especially young adults and pregnant women, by improving access to comprehensive and specialized healthcare services. If passed, it could lead to better health outcomes and quality of life for those living with sickle cell disease in participating states.

Policy Areas

Primary Policy Area

Health

Related Subjects

Blood and blood diseases

Congressional oversight

Government information and archives

Health care coverage and access

Health information and medical records

Health programs administration and funding

Health promotion and preventive care

Health technology, devices, supplies

Hereditary and development disorders

Home and outpatient care

+3 more

Scope & Jurisdiction

Jurisdiction Level

federal

Congressional Session

119th Congress

Citation Reference

1672, 119th Congress (2025). "Maintaining Investments in New Innovation Act". Source: Voter's Right Platform. https://votersright.org/bills/118-hr-1672